Sumathi Best Television Current Reporting Award

Agrify Receives Extended Stay of Suspension from Nasdaq

Retrieved on: 
Wednesday, November 8, 2023

TROY, Mich., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on November 6, 2023 it received a letter from the Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that the stay of suspension for Agrify’s common stock will be extended until a hearing before the Panel and issuance of a final Panel decision.

Key Points: 
  • TROY, Mich., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on November 6, 2023 it received a letter from the Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that the stay of suspension for Agrify’s common stock will be extended until a hearing before the Panel and issuance of a final Panel decision.
  • The Staff Determination had no immediate effect and will not immediately result in the suspension of trading or delisting of Agrify’s shares of common stock.
  • Agrify filed amended Forms 10-Q on October 2, 2023 with the required restated financial statements.
  • There can be no assurance that Agrify will be able to file the Delinquent Reports within the extension period granted by the Panel.

Orthofix Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 8, 2023

As of September 30, 2023, cash totaled $33.7 million, compared to $50.7 million as of December 31, 2022.

Key Points: 
  • As of September 30, 2023, cash totaled $33.7 million, compared to $50.7 million as of December 31, 2022.
  • As of September 30, 2023, the Company had $70.0 million in borrowings outstanding under its five year $175 million secured revolving credit facility.
  • For additional discussion of the Financing Agreement, see the Company's Current Report on Form 8-K as filed with the SEC on November 8, 2023.
  • As of the date hereof, the Company expects the following financial results for the year ended December 31, 2023.

Spire Global Announces Strong Third Quarter 2023 Results; Reaffirms Expectations for Positive Cash Flow from Operations by Year End; Increases Revenue and Earnings Guidance

Retrieved on: 
Wednesday, November 8, 2023

Please see the reconciliation tables at the end of this release for the reconciliation of GAAP and non-GAAP results.

Key Points: 
  • Please see the reconciliation tables at the end of this release for the reconciliation of GAAP and non-GAAP results.
  • Spire adjusts the following items from one or more of its non-GAAP financial measures:
    Loss on satellite deorbit, launch failure and decommissioning.
  • Spire excludes these items as they do not reflect the underlying cash flows or operational results of the business.
  • Spire defines free cash flow as net cash used in operating activities reduced by purchases of property and equipment.

The Vita Coco Company, Inc. Announces Secondary Offering of Common Stock

Retrieved on: 
Monday, November 6, 2023

NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (“Vita Coco Company” or the “Company”) (Nasdaq: COCO), a leading high-growth platform of better-for-you beverage brands, today announced the launch of an underwritten secondary offering (the “Offering”) by Verlinvest Beverages SA (the “Selling Stockholder”) of 4,000,000 shares of the Company’s common stock (“Common Stock”).

Key Points: 
  • NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (“Vita Coco Company” or the “Company”) (Nasdaq: COCO), a leading high-growth platform of better-for-you beverage brands, today announced the launch of an underwritten secondary offering (the “Offering”) by Verlinvest Beverages SA (the “Selling Stockholder”) of 4,000,000 shares of the Company’s common stock (“Common Stock”).
  • The Company is not selling any shares of Common Stock in the Offering and will not receive any proceeds from the Offering.
  • BofA Securities is acting as the sole underwriter of the Offering.
  • All statements other than statements of historical facts contained in this press release may be forward-looking statements, including statements regarding the expected sale of Common Stock by the Selling Stockholder in the Offering.

U.S. Navy Funds Mercury to Develop Photonics Chiplet Manufacturing Capability for Defense Applications

Retrieved on: 
Thursday, November 2, 2023

Compared to conventional copper connections, photonics uses optical fibers to enable orders of magnitude improvement in data bandwidth at a fraction of the power needed.

Key Points: 
  • Compared to conventional copper connections, photonics uses optical fibers to enable orders of magnitude improvement in data bandwidth at a fraction of the power needed.
  • These chiplet devices use optical technology to move data through systems such as data centers at speeds in excess of a terabyte per second.
  • Mercury plans to develop miniaturized and ruggedized packages using photonics chiplets for defense applications to allow edge sensor data to be ingested much faster, enabling faster decision-making in next-generation radar and electronic warfare systems.
  • “We are excited to partner with the Navy to bring this game-changing commercial technology to the defense community,” said Tom Smelker, Mercury’s GM of Microsystems.

Aquestive Therapeutics Completes $45 Million Debt Refinancing

Retrieved on: 
Thursday, November 2, 2023

WARREN, N.J., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced the refinancing of its existing debt facility.

Key Points: 
  • WARREN, N.J., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced the refinancing of its existing debt facility.
  • The Notes are senior secured obligations of Aquestive and will mature on November 1, 2028, unless earlier redeemed or repurchased in accordance with their terms.
  • “We are pleased to announce this new debt facility,” said Daniel Barber, CEO of Aquestive Therapeutics.
  • “The structure of this refinancing transaction removes a significant near-term financial overhang and reduces the Company’s principal and interest payments by approximately $28 million through June of 2025.

VYNE Therapeutics Announces Closing of Previously Announced Private Placement of $88.2 Million

Retrieved on: 
Wednesday, November 1, 2023

BRIDGEWATER, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced the closing of its previously announced private placement financing (the “PIPE”).

Key Points: 
  • BRIDGEWATER, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced the closing of its previously announced private placement financing (the “PIPE”).
  • Each pre-funded warrant has an exercise price of $0.0001 per share of common stock and is immediately exercisable and will remain exercisable until exercised in full.
  • The PIPE was priced to satisfy the “Minimum Price” requirement set forth in the Nasdaq listing rules.
  • LifeSci Capital LLC acted as the exclusive placement agent for the PIPE.

Eightco Holdings Announces Successful Initial Payment in Prepayment and Redemption Agreement, Clearing All Outstanding Warrants with Certain Investor

Retrieved on: 
Monday, October 30, 2023

Safety Harbor, Florida, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company”) proudly announces the successful completion of the initial payment as part of the previously disclosed Prepayment and Redemption Agreement (the “Prepayment Agreement”) entered into by the Company with an accredited investor (the “Investor”).

Key Points: 
  • Safety Harbor, Florida, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company”) proudly announces the successful completion of the initial payment as part of the previously disclosed Prepayment and Redemption Agreement (the “Prepayment Agreement”) entered into by the Company with an accredited investor (the “Investor”).
  • With the finalization of the $3,000,000 initial payment (the “Initial Payment”), Eightco Holdings Inc. has achieved significant financial milestones, including the full repayment of the 2022 Note, reduction of the 2023 Note, and the complete and permanent redemption of the 2023 Warrant (each of the foregoing terms as defined in the Prepayment Agreement), completing the elimination of all outstanding warrants held by the Investor.
  • For additional information about this milestone, please refer to the Current Report on Form 8-K filed by the Company on October 24, 2023.
  • For more information about Eightco Holdings Inc. and its latest developments, please visit www.8co.holdings .

Interface Reports Third Quarter 2023 Results

Retrieved on: 
Friday, November 3, 2023

Interface, Inc. (Nasdaq: TILE), a worldwide commercial flooring company and global leader in sustainability, today announced results for the third quarter ended October 1, 2023.

Key Points: 
  • Interface, Inc. (Nasdaq: TILE), a worldwide commercial flooring company and global leader in sustainability, today announced results for the third quarter ended October 1, 2023.
  • Third quarter 2023 adjusted operating income ("AOI") was $32.4 million versus AOI of $31.2 million in the third quarter of 2022.
  • Third quarter 2023 adjusted net income was $16.4 million, or $0.28 per diluted share, versus third quarter 2022 adjusted net income of $17.4 million, or $0.30 per diluted share.
  • Interface will host a conference call on November 3, 2023, at 8:00 a.m. Eastern Time, to discuss its third quarter 2023 results.

Chimera Declares Fourth Quarter 2023 Common and Preferred Stock Dividends

Retrieved on: 
Thursday, November 2, 2023

The Board of Directors of Chimera announced the declaration of its fourth quarter cash dividend of $0.50 per share of 8% Series A Cumulative Redeemable Preferred Stock.

Key Points: 
  • The Board of Directors of Chimera announced the declaration of its fourth quarter cash dividend of $0.50 per share of 8% Series A Cumulative Redeemable Preferred Stock.
  • The Board of Directors of Chimera also announced the declaration of its fourth quarter cash dividend of $0.50 per share of 8% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock.
  • The Board of Directors of Chimera also announced the declaration of its fourth quarter cash dividend of $0.484375 per share of 7.75% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock.
  • The Board of Directors of Chimera also announced the declaration of its fourth quarter cash dividend of $0.50 per share of 8% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock.